Enhanced Recovery After Surgery(ERAS) for Gastric Cancer and Perioperative Nutritional Status
Primary Purpose
Nutrition Disorders
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
perioperational nutrition surpport
Sponsored by
About this trial
This is an interventional supportive care trial for Nutrition Disorders focused on measuring gastric cancer, Enhanced recovery after surgery
Eligibility Criteria
Inclusion Criteria:
- A preoperative cancer stage of T2, T3, T4, Any N, M0 without digestive obstruction confirmed by whole body CT scan, which could be treated with laparoscopic gastrectomy;
- age 18-75 years;
- pathologic confirmation of gastric adenocarcinoma by endoscopic biopsy;
- normal hematological, renal, hepatic, and cardiac parameters,American Society of Anesthesiology (ASA) score < III without severe systemic disease;
- no history of treatment with neoadjuvant chemotherapy and/or radiotherapy
- PG-SGA score ≥2,<9
Exclusion Criteria:
- patients requiring conversion to open gastrectomy
- excessive bleeding (˃ 500 mL);and patients opting out of the study.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Preoperational nutrition support group
Conventional group
Arm Description
Scored patient-generated subjective global assessment(PG-SGA) ≥2,<9 Oral enteral nutrition support(25 kcal/kg or 1.5 g protein/kg) for 3 days before operation
PG-SGA ≥2,<9
Outcomes
Primary Outcome Measures
complication
fever;wound infection;post-operation bleeding;ileus;stenosis;leakage
Secondary Outcome Measures
Full Information
NCT ID
NCT03043183
First Posted
February 2, 2017
Last Updated
February 3, 2017
Sponsor
The First Hospital of Jilin University
1. Study Identification
Unique Protocol Identification Number
NCT03043183
Brief Title
Enhanced Recovery After Surgery(ERAS) for Gastric Cancer and Perioperative Nutritional Status
Official Title
The Effect of Perioperative Nutritional Status on Enhanced Recovery After Surgery for Gastric Cancer
Study Type
Interventional
2. Study Status
Record Verification Date
February 2017
Overall Recruitment Status
Unknown status
Study Start Date
March 1, 2017 (Anticipated)
Primary Completion Date
March 1, 2021 (Anticipated)
Study Completion Date
September 30, 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The First Hospital of Jilin University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
This study is a prospective, single-center, randomized controlled trial. The study protocol was approved by the Ethics Committee at the First Hospital of Jilin University.The perioperation nutritional status will be assessed in gastric cancer patients within ERAS protocols.The ERAS patients were randomly divided into perioperational nutrition support group and conventional pathway group . Inter-group differences were evaluated for nutritional index,clinical recovery index, complications etc.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Nutrition Disorders
Keywords
gastric cancer, Enhanced recovery after surgery
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
1400 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Preoperational nutrition support group
Arm Type
Experimental
Arm Description
Scored patient-generated subjective global assessment(PG-SGA) ≥2,<9 Oral enteral nutrition support(25 kcal/kg or 1.5 g protein/kg) for 3 days before operation
Arm Title
Conventional group
Arm Type
No Intervention
Arm Description
PG-SGA ≥2,<9
Intervention Type
Procedure
Intervention Name(s)
perioperational nutrition surpport
Intervention Description
Oral enteral nutrition support(25 kcal/kg or 1.5 g protein/kg) for 3 days before operation
Primary Outcome Measure Information:
Title
complication
Description
fever;wound infection;post-operation bleeding;ileus;stenosis;leakage
Time Frame
30 days after operation
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
A preoperative cancer stage of T2, T3, T4, Any N, M0 without digestive obstruction confirmed by whole body CT scan, which could be treated with laparoscopic gastrectomy;
age 18-75 years;
pathologic confirmation of gastric adenocarcinoma by endoscopic biopsy;
normal hematological, renal, hepatic, and cardiac parameters,American Society of Anesthesiology (ASA) score < III without severe systemic disease;
no history of treatment with neoadjuvant chemotherapy and/or radiotherapy
PG-SGA score ≥2,<9
Exclusion Criteria:
patients requiring conversion to open gastrectomy
excessive bleeding (˃ 500 mL);and patients opting out of the study.
12. IPD Sharing Statement
Learn more about this trial
Enhanced Recovery After Surgery(ERAS) for Gastric Cancer and Perioperative Nutritional Status
We'll reach out to this number within 24 hrs